Zurich, Switzerland

Francois Dewarrat

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Zürich, CH (2015)
  • Zurich, CH (2017)

Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Francois Dewarrat in Glucose Detection Technology

Introduction

Francois Dewarrat is an accomplished inventor based in Zurich, Switzerland. He has made significant contributions to the field of medical technology, particularly in non-invasive glucose detection methods. With a total of 2 patents, his work is paving the way for advancements in health monitoring.

Latest Patents

Dewarrat's latest patents include a "Device for determining the glucose level in body tissue" and a "Sensing device for body tissue properties." The first patent describes an apparatus for non-invasive glucose detection that utilizes an electrical detection device to measure the response of tissue or blood to electric fields at varying frequencies. This innovative approach combines signals from low and high frequencies to enhance accuracy, while additional sensors improve measurement reliability. The second patent focuses on a device designed to measure parameters of living tissue, particularly glucose levels, using a substrate with electrodes and optical reflection detectors to ensure precise readings.

Career Highlights

Francois Dewarrat has established himself as a key figure in the medical technology sector through his work at Biovotion AG. His inventions are not only innovative but also practical, addressing real-world health monitoring challenges. His dedication to improving glucose detection methods showcases his commitment to advancing healthcare technology.

Collaborations

Dewarrat has collaborated with notable professionals in his field, including Andreas Caduff and Mark Stuart Talary. These partnerships have contributed to the development and refinement of his innovative technologies.

Conclusion

Francois Dewarrat's contributions to glucose detection technology exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving patient care through advanced medical devices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…